Findings

What do systematic reviews say?

4,808 questions · 8,953 findings · 827 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1,891 · 21.1%GRADE not reported 380 · 4.2%Very low 2,100 · 23.5%Low 2,449 · 27.4%Moderate 1,684 · 18.8%High 449 · 5%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Myofunctional therapy vs medical treatment

Quality of sleep · obstructive sleep apnoea

1 finding from 1 review

Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 26 participants
Low

Myofunctional therapy vs medical treatment

Snoring frequency: change from baseline. · obstructive sleep apnoea

1 finding from 1 review

Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 26 participants
Low

Myofunctional therapy vs medical treatment

Snoring intensity: change from baseline. · obstructive sleep apnoea

1 finding from 1 review

Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 26 participants
Low

Myofunctional therapy vs waiting list control

Daytime sleepiness (ESS): change from baseline. · obstructive sleep apnoea

1 finding from 1 review

Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 25 participants
Low

Myofunctional therapy vs waiting list control

Quality of sleep · obstructive sleep apnoea

1 finding from 1 review

Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 25 participants
Low

Myofunctional therapy vs waiting list control

AHI score change. · obstructive sleep apnoea

1 finding from 1 review

Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 25 participants
Low

Myofunctional therapy vs continuous positive airway pressure (CPAP)

Daytime sleepiness (ESS): endpoint score. · obstructive sleep apnoea

1 finding from 1 review

Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 54 participants
Low

Sclerotherapy (chromated glycerin) vs sclerotherapy (any sclerosant)

Resolution or improvement of telangiectasias ( · people with telangiectasias and reticular veins

1 finding from 1 review

Treatment for telangiectasias and reticular veins 2021 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 125 participants
Low

Sclerotherapy (chromated glycerin) vs sclerotherapy (any sclerosant)

Adverse events ‐ hyperpigmentation ( · people with telangiectasias and reticular veins

Sclerotherapy (chromated glycerin) showed no clear difference in adverse events ‐ hyperpigmentation ( compared with sclerotherapy (any sclerosant) (low certainty).

1 finding from 1 review

Treatment for telangiectasias and reticular veins 2021 · Cochrane Headline outcomes only
RR 0.49 [0.09, 2.5]
2 studies · 125 participants
Low

Sclerotherapy (chromated glycerin) vs sclerotherapy (any sclerosant)

Adverse events ‐ matting ( · people with telangiectasias and reticular veins

Sclerotherapy (chromated glycerin) showed no clear difference in adverse events ‐ matting ( compared with sclerotherapy (any sclerosant) (low certainty).

1 finding from 1 review

Treatment for telangiectasias and reticular veins 2021 · Cochrane Headline outcomes only
RR 0.31 [0.01, 7.53]
1 study · 99 participants
Low

Sclerotherapy (chromated glycerin) vs sclerotherapy (any sclerosant)

Pain ( · people with telangiectasias and reticular veins

Sclerotherapy (chromated glycerin) showed no clear difference in pain ( compared with sclerotherapy (any sclerosant) (low certainty).

1 finding from 1 review

Treatment for telangiectasias and reticular veins 2021 · Cochrane Headline outcomes only
RR 1.5 [0.3, 7.55]
1 study · 26 participants
Low

Sclerotherapy (chromated glycerin) vs sclerotherapy (any sclerosant)

Recurrence · people with telangiectasias and reticular veins

The review found no eligible studies for this question.

1 finding from 1 review

Treatment for telangiectasias and reticular veins 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Sclerotherapy (chromated glycerin) vs sclerotherapy (any sclerosant)

Time to resolution · people with telangiectasias and reticular veins

The review found no eligible studies for this question.

1 finding from 1 review

Treatment for telangiectasias and reticular veins 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Sclerotherapy (chromated glycerin) vs sclerotherapy (any sclerosant)

Quality of life · people with telangiectasias and reticular veins

The review found no eligible studies for this question.

1 finding from 1 review

Treatment for telangiectasias and reticular veins 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Adjunctive couple or family therapy vs structured or non‐specific individual therapy alone

Severity of PTSD symptoms · post‐traumatic stress disorder (PTSD)

1 finding from 1 review

Couple and family therapies for post‐traumatic stress disorder (PTSD) 2019 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Adjunctive couple or family therapy vs structured or non‐specific individual therapy alone

Dyadic adjustment · post‐traumatic stress disorder (PTSD)

1 finding from 1 review

Couple and family therapies for post‐traumatic stress disorder (PTSD) 2019 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Adjunctive couple or family therapy vs structured or non‐specific individual therapy alone

Family member severity of depression · post‐traumatic stress disorder (PTSD)

1 finding from 1 review

Couple and family therapies for post‐traumatic stress disorder (PTSD) 2019 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Adjunctive couple or family therapy vs structured or non‐specific individual therapy alone

Family member severity of anxiety · post‐traumatic stress disorder (PTSD)

1 finding from 1 review

Couple and family therapies for post‐traumatic stress disorder (PTSD) 2019 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Adjunctive couple or family therapy vs structured or non‐specific individual therapy alone

Severity of depression · post‐traumatic stress disorder (PTSD)

1 finding from 1 review

Couple and family therapies for post‐traumatic stress disorder (PTSD) 2019 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Adjunctive couple or family therapy vs structured or non‐specific individual therapy alone

Anxiety · post‐traumatic stress disorder (PTSD)

1 finding from 1 review

Couple and family therapies for post‐traumatic stress disorder (PTSD) 2019 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported